Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Avoid Pod Point Group Holdings (PODP) by Steve Moore in ShareProphets
- Buy Tharisa (DI) (THS) by Hot Stock Rockets in ShareProphets
- Avoid Cyanconnode Holdings (CYAN) by Steve Moore in ShareProphets
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Avoid Zenova Group (ZED) by Steve Moore in ShareProphets
- Hold Team17 Group (TM17) by Jefferies
- Hold BP (BP.) by Mark David Hartley in The Motley Fool
- Buy Intertek Group (ITRK) by Redburn Partners
- Buy IQE (IQE) by Numis
- Hold 888 Holdings (DI) (888) by Numis
- Buy Oxford Metrics (OMG) by Numis
- Buy Hunting (HTG) by Kepler Cheuvreux
- Add Man Group (EMG) by Numis
- Buy NATWEST GROUP (NWG) by Peel Hunt
- Overweight VinaCapital Vietnam Opportunity Fund Ltd. (VOF) by Barclays
- Hold Lloyds Banking Group (LLOY) by Peel Hunt
- Overweight Victrex plc (VCT) by Barclays
- Buy Barclays (BARC) by Peel Hunt
- Equal Weight Johnson Matthey (JMAT) by Barclays
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,302 open tips for GSK (GSK)
| Latest Bid : 1,596.00p | Latest Ask : 1,597.00p |
| High Today : 1,598.50p | Low Today : 1,575.00p |
| This Years High : 1,711.20p | This Years Low : 1,316.00p |
| Volume : 1,568,211 | MKT Cap : £65700.58M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | John Choong | Premium Only | 2023-09-13 17:00:00 13/09/2023 | 8.57% |
| Buy | Royston Wild | Premium Only | 2023-09-13 04:50:00 13/09/2023 | 8.90% |
| Underweight | JP Morgan | Premium Only | 2023-09-08 15:16:00 08/09/2023 | -11.73% |
| Buy | Societe Generale | Premium Only | 2023-09-06 07:46:00 06/09/2023 | 16.84% |
| Buy | Deutsche Bank | Premium Only | 2023-09-05 16:45:00 05/09/2023 | 24.76% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,596.00p | Latest Ask : 1,597.00p |
| High Today : 1,598.50p | Low Today : 1,575.00p |
| This Years High : 1,711.20p | This Years Low : 1,316.00p |
| Volume : 1,568,211 | MKT Cap : £65700.58M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | John Choong | Premium Only | 2023-09-13 17:00:00 13/09/2023 | 8.57% |
| Buy | Royston Wild | Premium Only | 2023-09-13 04:50:00 13/09/2023 | 8.90% |
| Underweight | JP Morgan | Premium Only | 2023-09-08 15:16:00 08/09/2023 | -11.73% |
| Buy | Societe Generale | Premium Only | 2023-09-06 07:46:00 06/09/2023 | 16.84% |
| Buy | Deutsche Bank | Premium Only | 2023-09-05 16:45:00 05/09/2023 | 24.76% |